DC
BMY icon

Deschaine & Company’s Bristol-Myers Squibb BMY Stock Holding History

Deschaine & Company’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		$737K Buy
11,080
+400
+4% +$26.4K 1.16% 35
2015
Q1 		$689K Sell
10,680
-900
-8% -$56.3K 1.13% 38
2014
Q4 		$684K Buy
+11,580
New +$653K 1.03% 42

Other funds holding BMY

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Deschaine & Company's BMY Position: Q2 2015 in Review

Deschaine & Company increased its Bristol-Myers Squibb (BMY) stake by 3.7% in Q2 2015, buying an estimated $26.4K and bringing the position to 11,080 shares worth $737K. The position accounts for 1.16% of the portfolio, ranked #35.

Deschaine & Company first reported a position in BMY in Q4 2014 and has held it in 3 quarters since. 1,448 funds tracked by Wall St. Rank hold BMY as of Q2 2015.

  • Deschaine & Company held 11,080 shares of Bristol-Myers Squibb worth $737K as of Q2 2015.
  • Deschaine & Company bought 400 Bristol-Myers Squibb shares in Q2 2015, an estimated $26.4K.
  • Bristol-Myers Squibb made up 1.16% of Deschaine & Company's portfolio in Q2 2015, its #35 holding.
  • Deschaine & Company first reported a position in Bristol-Myers Squibb in Q4 2014 and has held it in 3 quarters since.
  • 1,448 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2015.

Based on Deschaine & Company's 13F filing for Q2 2015, filed 30 Jul 2015.